The clinical application known as "Clinical study of human umbilical cord mesenchymal stem cells (19#iSCLife^®-CSD) for the treatment of uterine traumatic healing failure" with stem cell product has been approved by the state and fully supported by Professor Zhang Weishe, director of the Department of Obstetrics and Gynecology, Xiangya Hospital.